Intestinal metaplasia subtyping: Evaluation of Gomori's aldehyde fuchsin for routine diagnostic use

Histopathology

Volumn 31, Issue 3, 1997, Pages 277-283

  Shah, K A ^a   Deacon, A J ^b   Dunscombe, P ^b   Price, A B ^b  

^a NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Carcinoma; Gormori's aldehyde fuchsin; High iron diamine; Histochemistry; Intestinal metaplasia; Oesophagus; Stomach; Subtyping

Indexed keywords

ARTICLE; ESOPHAGUS CARCINOMA; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; PATHOGENESIS; PRIORITY JOURNAL; STOMACH CARCINOMA;

EID: 0030983887     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.2110847.x     Document Type: Article

References (32)

1. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J. Clin. Pathol. 1980; 33: 711-721.
2. Chejfec G, Schnell T, Sontag S, Barrett's esophagus. A preneoplastic disorder. Am. J. Clin. Pathol. 1992; 98: 5-7.
3. Winters C, Spurling TJ, Chobanian SJ et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-124.
4. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988; 48: 3554-3560.
5. Filipe MI, Munoz N, Matko I et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int. J. Cancer 1994; 57: 324-329.
6. Jass JR, Filipe MI. Sulphomucins and precancerous lesions of the human stomach. Histopathology 1980; 4: 271-279.
7. Silva S, Filipe MI. Intestinal metaplasia and its variants in the gastric mucosa of Portugese subjects: a comparative analysis of biopsy and gastrectomy material. Hum. Pathol. 1986; 17: 988-995.
8. Ramesar KC, Sanders DS, Hopwood D. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J. Clin. Pathol. 1987; 40: 1287-1290.
9. Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986; 10: 1271-1277.
10. Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller M, Fenoglio-Preiser CM. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum. Pathol. 1994; 25: 968-981.
11. Haggitt RC, Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 1994; 25: 982-993.
12. Spicer SS. Diamine methods for differentiating mucosubstances histochemically. J. Histochem. Cytochem. 1965; 13: 211-234.
13. Spicer SS, Meyer DB. Histochemical differentiation of acid mucopolysaccharides by means of combined aldehyde fuchsinalcian blue staining. Am. J. Clin. Pathol. 1960; 33: 453-460.
14. Jass JR, Filipe MI. The mucin profiles of normal gastric mucosa. intestinal metaplasia and its variants and gastric carcinoma. Histochem. J. 1981; 13: 913-939.
15. Rigby HS, Warren BF, Diamond J, Carter C, Bradfield JWB. Colour perception in pathologists: the Farnsworth-Munsell 100-hue test. J. Clin. Pathol. 1991; 44: 745-748.
16. Gomori G. Aldehyde Fuchsin: a new stain fur elastic tissue. Am. J. Clin Pathol. 1950; 20: 665-666.
17. Abul-Haj SK, Rinehart JF. Fuchsin-aldehyde staining of sulphate mucopolysaccharides and related substances. J. Nat. Cancer Inst. 1952; 13: 232-233.
18. Cook HC. Carbohydrates. In Bancroft JD and Stevens A eds. Theory and Practice of Histological techniques. Edinburgh: Churchill Livingstone, 1996; 173-212.
19. Rothery GA, Patterson JE, Stoddard CJ, Day DW. Histological and histochemical changes in the columnar lined (Barrett's) oesophagus. Gut 1986; 27: 1062-1068.
20. Filipe MI, Potet F, Bogomoletz WV et al. Incomplete sulphomucin-secreling intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres, Gut 1985; 26: 1319-1326.
21. Sipponen P. Intestinal metaplasia and gastric carcinoma. Ann. Clin. Res. 1981; 13: 139-143.
22. Williams GT. Transitional mucosa of the large intestine. Commentary. Histopathology 1985; 9: 1237-1243.
23. Tosi P, Filipe MI, Luzi P et al. Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry. J. Pathol. 1993; 169: 73-78.
24. Gottfried MR, McClave SA, Worth Boyce H. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus). Am. J. Clin. Pathol. 1989; 92: 741-746.
25. Peuchmaur M, Potet F, Goldfain D, Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): a prospective biopsy study. J. Clin. Pathol. 1984; 37: 607-610.
26. Reid BJ, Weinstein WM. Barrett's esophagus and adenocarcinoma. Ann. Rev. Med. 1987; 38: 477-492.
27. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614-621.
28. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32: 1110-1113.
29. Tosi P, Filipe MI, Baak JP et al. Morphometric definition and grading of gastric intestinal metaplasia. J. Pathol. 1990; 161: 201-208.
30. Genta RM. Helicobacter pylori as a promoter of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur. J. Gastroenterol. Hepatol. 1995; 7: S25-S30.
31. Kuipers EJ, Uyterlinde AM, Pena AS et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-1528.
32. Sobala GM, O'Connor HJ, Dewer EP, King RFG, Axon ATR, Dixon MF. Bile reflux and intestinal metaplasia in gastric mucosa. J. Clin. Pathol. 1993; 46: 235-240.